Can a new drug ease painful skin flares?
NCT ID NCT06374212
First seen Jan 25, 2026 · Last updated May 02, 2026 · Updated 21 times
Summary
This study tests if anifrolumab, a drug that targets inflammation, can reduce symptoms of hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. About 15 adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks. Researchers will measure changes in lesion counts and quality of life, with a follow-up 12 weeks later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UNC Dermatology and Skin Cancer Center
Chapel Hill, North Carolina, 27516, United States
Conditions
Explore the condition pages connected to this study.